Coming soon
For Potential Authors
Page and color charges are waived for the first year of publication and the final version of accepted manuscripts will be posted on the web site promptly. For additional information on how to submit your manuscript please click here.
Editors-in-Chief
Carlos López-Larrea
Hospital Universitario Central de Asturias
Oviedo, Spain
Fundación Renal "Iñigo Álvarez de Toledo"
Madrid, Spain
Riitta Lahesmaa
Molecular Immunology Group
Turku Centre for Biotechnology
Turku, Finland
José R. Regueiro
Universidad Complutense
Madrid, Spain
Print ISSN: 2324-9625
Online ISSN: 2324-9633
Immunomics will soon be accepting submissions
Immunomics utilizes an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.
Submit your paper to Immunomics (Coming Soon!).
About Immunomics
Immunomics is a peer-reviewed journal that publishes high-quality research addressing systems biology in the field of Immunology by using high-throughput omics approaches. Immunomics covers genomics, proteomics, glycomics, lipidomics and bioinformatics of immune molecular and cellular interactions (the immunome) in physiology, pathology and therapy. Immunomics is planned as a unique high-profile journal with a broad international audience. The launch of this journal reflects the tremendous progress in the field of immunomics over the past decade.
Mission Statement
Our goal is to establish Immunomics as the leading journal in the field by providing a forum where omic approaches to immunity reveal its holistic underpinnings.
Articles
Immunomics publishes several types of articles including Original Research Papers, Short Communications, Reviews, Technical Papers and Views. Reviews and Views will generally be invited. We also anticipate special issues that are devoted to particular areas of research. Suggestions for specialized topics are welcome.
Advertisements
